IHS Chemical Week

EnviroTech :: R&D

Jubilant, Amgen Enter Drug Discovery Deal

12:15 PM MDT | July 21, 2008 | Deepti Ramesh

Jubilant Biosys Ltd. (Bangalore, India), a subsidiary of Jubilant Organosys (Noida), says it has entered into a drug discovery partnership with biotechnology firm Amgen (Thousand Oaks, CA). The companies will collaborate to develop a novel drug portfolio across multiple therapeutic areas, Jubilant says. The agreement calls for Jubilant to develop early preclinical candidates from Amgen’s early discovery efforts, for an initial term of three years. Amgen will have responsibility for subsequent preclinical and clinical development and commercialization and...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa